Pfizer Gets GSK Patents For RSV Jab Axed In UK
A London judge has granted Pfizer's bid to nix two patents protecting GSK's blockbuster vaccine for the respiratory syncytial virus, blocking GSK's future infringement claims a month after launching its own...To view the full article, register now.
Already a subscriber? Click here to view full article